Abstract
Symptom monitoring using patient-reported outcomes (PROs) is not common in pediatric oncology, despite interest from stakeholders—including patients, families, clinicians, and regulatory organizations—and proven clinical benefit in adult oncology. This article examines the foundational data for patient-reported symptom reporting in this population and posits the next investigative steps toward the implementation of patient-reported symptom monitoring in the care and research of pediatric oncology patients. The reasoning behind, and feasibility of, monitoring symptoms in pediatric oncology patients using PRO measures are discussed, as well as specific tools that have been developed to track symptoms in this population, including innovative electronic self-reporting platforms built to engage children in the symptom reporting process. Aspects of engaging both patients and clinicians in the symptom self-report process are reviewed, as are the experiences of “early adopters” of this process in pediatric oncology and across pediatrics. It is clear that there are key issues that remain regarding the use of PROs for symptom monitoring, including selection of specific outcomes to monitor, how to resolve discrepant reports, and determination of benefit. The next steps for investigation of these issues are discussed. Unanswered questions notwithstanding, work should continue to make patient-reported symptom monitoring an established, evidence-based part of routine and research practice in pediatric oncology.
Similar content being viewed by others
References
Ullrich CK, Billett AL, Berde CB. Symptom management in children with cancer. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE, editors. Nathan and Oski’s hematology of infancy and childhood. Canada: Elsevier Health Sciences; 2009. pp. 2349–96.
Kirch R, Reaman G, Feudtner C, Wiener L, Schwartz LA, Sung L, et al. Advancing a comprehensive cancer care agenda for children and their families: institute of Medicine Workshop highlights and next steps. CA Cancer J Clin. 2016;66(5):398–407.
The National Cancer Institute. Blue Ribbon Panel Report 2016, pp 1–74.
Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 2017;318(2):197–8.
Schepers SA, Haverman L, Zadeh S, Grootenhuis MA, Wiener L. Healthcare professionals’ preferences and perceived barriers for routine assessment of patient-reported outcomes in pediatric oncology practice: moving toward international processes of change. Pediatr Blood Cancer. 2016;63(12):2181–8.
Woodgate RL, Degner LF. Expectations and beliefs about children’s cancer symptoms: perspectives of children with cancer and their families. Oncol Nurs Forum. 2007;30(3):479–91.
Woodgate RL, Degner LF, Yanofsky R. A different perspective to approaching cancer symptoms in children. J Pain Symptom Manage. 2003;26(3):800–17.
Carter B. Chronic pain in childhood and the medical encounter: professional ventriloquism and hidden voices. Qual Health Res. 2002;12(1):28–41.
Sikorskii A, Given CW, Given B, Jeon S, You M. Differential symptom reporting by mode of administration of the assessment. Med Care. 2009;47(8):866–74.
Takeuchi EE, Keding A, Awad N, Hofmann U, Campbell LJ, Selby PJ, et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J Clin Oncol. 2011;29(21):2910–7.
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.
Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT, et al. The measurement of symptoms in children with cancer. J Pain Symptom Manage. 2000;19(5):363–77.
Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, Pinkerton CR, et al. The measurement of symptoms in young children with cancer: the validation of the memorial symptom assessment scale in children aged 7–12. J Pain Symptom Manag. 2002;23(1):10–6.
Goodenough B. Children’s self-report of symptoms and anticipation for symptom change. J Cancer Pain Symptom Palliat. 2005;1(2):3–13.
Baggott C, Cooper BA, Marina N, Matthay KK, Miaskowski C. Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy. Cancer Nurs. 2012;35(1):19–28.
Zhukovsky DS, Rozmus CL, Robert RS, Bruera E, Wells RJ, Chisholm GB, et al. Symptom profiles in children with advanced cancer: patient, family caregiver, and oncologist ratings. Cancer. 2015;121(22):4080–7.
Rodgers C, Kollar D, Taylor O, Bryant R, Crockett K, Gregurich MA, et al. Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment. Cancer Nurs. 2012;35(3):203–10.
Rodgers C, Wills-Bagnato P, Sloane R, Hockenberry M. Health-related quality of life among children and adolescents during hematopoietic stem cell transplant recovery. J Pediatr Oncol Nurs. 2015;32(5):329–36 (SAGE Publications).
Menard JC, Hinds PS, Jacobs SS, Cranston K, Wang J, DeWalt DA, et al. Feasibility and acceptability of the patient-reported outcomes measurement information system measures in children and adolescents in active cancer treatment and survivorship. Cancer Nurs. 2014;37(1):66–74.
Baggott C, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper BA, et al. Changes in children’s reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy. J Pediatric Oncol Nurs. 2010;27(6):307–15 (SAGE PublicationsSage CA: Los Angeles, CA).
Dobrozsi S, Yan K, Hoffmann R, Panepinto J. Patient-reported health status during pediatric cancer treatment. Pediatr Blood Cancer. 2016;64(4):e26295.
Engelen V, Detmar S, Koopman H, Maurice-Stam H, Caron H, Hoogerbrugge P, et al. Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: is it effective? Pediatr Blood Cancer. 2011;58(5):766–74.
Lai J-S, Yount S, Beaumont JL, Cella D, Toia J, Goldman S. A patient-centered symptom monitoring and reporting system for children and young adults with cancer (SyMon-SAYS). Pediatr Blood Cancer. 2015;62(10):1813–8.
Dussel V, Orellana L, Soto N, Chen K, Ullrich C, Kang TI, et al. Feasibility of conducting a palliative care randomized controlled trial in children with advanced cancer: assessment of the PediQUEST study. J Pain Symptom Manage. 2015;49(6):1059–69.
Wolfe J, Orellana L, Cook EF, Ullrich C, Kang T, Geyer JR, et al. Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol. 2014;32(11):1119–26.
Tomlinson D, Dupuis LL, Gibson P, Johnston DL, Portwine C, Baggott C, et al. Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Support Care Cancer. 2014;22(1):71–5 (Springer Berlin Heidelberg).
Reeve BB, Withycombe JS, Baker JN, Hooke MC, Lyons JC, Mowbray C, et al. The first step to integrating the child’s voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians. Pediatr Blood Cancer. 2013;60(7):1231–6.
Weaver MS, Reeve BB, Baker JN, Martens CE, McFatrich M, Mowbray C, et al. Concept-elicitation phase for the development of the pediatric Patient-Reported Outcome version of the Common Terminology Criteria for Adverse Events. Cancer. 2016;122(1):141–8.
DeWalt DA, Gross HE, Gipson DS, Selewski DT, DeWitt EM, Dampier CD, et al. PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Qual Life Res. 2015;24(9):2195–208.
Hinds PS, Nuss SL, Ruccione KS, Withycombe JS, Jacobs S, DeLuca H, et al. PROMIS pediatric measures in pediatric oncology: valid and clinically feasible indicators of patient-reported outcomes. Pediatr Blood Cancer. 2013;60(3):402–8.
Wolfe J, Orellana L, Ullrich C, Cook EF, Kang TI, Rosenberg A, et al. Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST study. J Clin Oncol. 2015;33(17):1928–35.
Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) [Internet]. healthcaredelivery.cancer.gov. [https://healthcaredelivery.cancer.gov/pro-ctcae/. Accessed 15 May 2017
Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244.
Reeve BB, McFatrich M, Pinheiro LC, Weaver MS, Sung L, Withycombe JS, et al. Eliciting the child’s voice in adverse event reporting in oncology trials: cognitive interview findings from the pediatric patient-reported outcomes version of the common terminology criteria for adverse events initiative. Pediatr Blood Cancer. 2016;64(3):e26261.
Reeve BB, McFatrich M, Pinheiro LC, Freyer DR, Basch EM, Baker JN, et al. Cognitive interview-based validation of the patient-reported outcomes version of the common terminology criteria for adverse events in adolescents with cancer. J Pain Symptom Manag. 2017;53(4):759–66.
Dupuis LL, Ethier M-C, Tomlinson D, Hesser T, Sung L. A systematic review of symptom assessment scales in children with cancer. BMC Cancer. BMC Cancer. 2012;12(1):1–1.
O’Sullivan C, Dupuis LL, Gibson P, Johnston DL, Baggott C, Portwine C, et al. Refinement of the symptom screening in pediatrics tool (SSPedi). Br J Cancer. 2014;111(7):1262–8.
O’Sullivan C, Dupuis LL, Gibson P, et al. Evaluation of the electronic self-report Symptom Screening in Pediatrics Tool (SSPedi). BMJ Support Palliat Care. doi:10.1136/bmjspcare-2015-001084.
Stinson JN, Jibb LA, Nguyen C, Nathan PC, Maloney AM, Dupuis LL, et al. Construct validity and reliability of a real-time multidimensional smartphone app to assess pain in children and adolescents with cancer. Pain. 2015;156(12):2607–15.
Fortier MA, Chung WW, Martinez A, Gago-Masague S, Sender L. Pain Buddy: a novel use of m-health in the management of children’s cancer pain. Comput Biol Med. 2016;76:202–14.
Primack BA, Carroll MV, McNamara M, Klem ML, King B, Rich M, et al. Role of video games in improving health-related outcomes: a systematic review. Am J Prev Med. 2012;42(6):630–8.
Coons SJ, Eremenco S, Lundy JJ, O’Donohoe P, O’Gorman H, Malizia W. Capturing patient-reported outcome (PRO) data electronically: the past, present, and promise of ePRO measurement in clinical trials. Patient Patient Cent Outcomes Res. 2014;8(4):301–9.
Kabali HK, Irigoyen MM, Nunez-Davis R, Budacki JG, Mohanty SH, Leister KP, et al. Exposure and use of mobile media devices by young children. Pediatr Am Acad Pediatrics. 2015;136(6):1044–50.
Bantug ET, Coles T, Smith KC, Snyder CF, Rouette J, Brundage MD, et al. Graphical displays of patient-reported outcomes (PRO) for use in clinical practice: what makes a PRO picture worth a thousand words? Patient Educ Couns. 2016;99(4):483–90.
Dobrozsi S, Panepinto J. Child and parent preferences for graphical display of patient-reported outcome data. Pediatr Blood Cancer. 2017;32(9):e26499.
Smith KC, Brundage MD, Tolbert E, Little EA, Bantug ET, Snyder CF, et al. Engaging stakeholders to improve presentation of patient-reported outcomes data in clinical practice. Support Care Cancer. 2016;24(10):4149–57 (Springer Berlin Heidelberg).
Engelen V, Haverman L, Koopman H, van Meeteren NS, van den Bergh EM, Vrijmoet-Wiersma J, et al. Development and implementation of a patient reported outcome intervention (QLIC-ON PROfile) in clinical paediatric oncology practice. Patient Educ Couns. 2010;81(2):235–44.
Schepers SA, Engelen VE, Haverman L, Caron HN, Hoogerbrugge PM, Kaspers GJL, et al. Patient reported outcomes in pediatric oncology practice: suggestions for future usage by parents and pediatric oncologists. Pediatr Blood Cancer. 2014;61(9):1707–10.
Bevans KB, Moon J, Carle AC, Mara CA, Lai J-S, DiMarco L, et al. Patient reported outcomes as indicators of pediatric health care quality. Acad Pediatr. 2014;14(5 Suppl):S90–6.
Kaplan HC, Thakkar SN, Burns L, Chini B, Dykes DM, McPhail GL, et al. Protocol of a pilot study of technology-enabled coproduction in pediatric chronic illness care. JMIR Res Protoc. 2017;6(4):e71.
Maude SL, Barrett D, Teachey DT, Grupp SA. Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. 2014;20(2):119–22.
Miller TP, Li Y, Kavcic M, Troxel AB, Huang Y-SV, Sung L, et al. Accuracy of adverse event ascertainment in clinical trials for pediatric acute myeloid leukemia. J Clin Oncol. 2016;34(13):1537–43.
Atkinson TM, Rogak LJ, Heon N, Ryan SJ, Shaw M, Stark LP, et al. Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting. J Cancer Res Clin Oncol. 2017;143(4):735–43.
Fromme EK, Eilers KM, Mori M, Hsieh Y-C, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485–90.
Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624–32.
Walker LS. Social consequences of children’s pain: when do they encourage symptom maintenance? J Pediatr Psychol. 2002;27(8):689–98.
Woodgate RL, Degner LF, Yanofsky R. A different perspective to approaching cancer symptoms in children. J Pain Sympt Manag. 2003;26(3):800–17.
Author information
Authors and Affiliations
Contributions
Allison Barz Leahy: literature review, development of central ideas and arguments, and preparation of manuscript. Chris Feudtner: refinement of central ideas and arguments; review and revision of manuscript; and final approval. Ethan Basch: concept design and refinement; review and revision of manuscript; and final approval.
Corresponding author
Ethics declarations
Funding
No specific funding source was used for the preparation of this article. Dr. Barz Leahy is supported by a National Institute of Health Grant, T32 HD060550-07.
Conflict of interest
Allison Barz Leahy: no conflicts of interest exist. Chris Feudtner: no conflicts of interest exist. Ethan Basch: no financial conflicts of interest exist. Dr. Basch’s research group has received grant funding from the National Cancer Institute and the Patient-Centered Outcomes Research Institute (PCORI) to support research on patient-reported outcomes.
Rights and permissions
About this article
Cite this article
Leahy, A.B., Feudtner, C. & Basch, E. Symptom Monitoring in Pediatric Oncology Using Patient-Reported Outcomes: Why, How, and Where Next. Patient 11, 147–153 (2018). https://doi.org/10.1007/s40271-017-0279-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40271-017-0279-z